Role for Human Immunodeficiency Virus Type 1 Tat Protein in Suppression of Viral Reverse Transcriptase Activity during Late Stages of Viral Replication
暂无分享,去创建一个
M. Wainberg | L. Rong | C. Liang | M. Götte | M. Kameoka | R. Russell
[1] M. Wainberg,et al. Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers. , 2000, Nucleic acids research.
[2] Hui Zhang,et al. Partial Rescue of the Vif-Negative Phenotype of Mutant Human Immunodeficiency Virus Type 1 Strains from Nonpermissive Cells by Intravirion Reverse Transcription , 2000, Journal of Virology.
[3] F. Kashanchi,et al. Cell Cycle-Regulated Transcription by the Human Immunodeficiency Virus Type 1 Tat Transactivator , 2000, Journal of Virology.
[4] K. Jeang,et al. Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.
[5] M. Kameoka,et al. HIV-1 Tat protein is poly(ADP-ribosyl)ated in vitro. , 1999, Biochemical and biophysical research communications.
[6] C. Ehresmann,et al. The Human Immunodeficiency Virus Type 1 Gag Polyprotein Has Nucleic Acid Chaperone Activity: Possible Role in Dimerization of Genomic RNA and Placement of tRNA on the Primer Binding Site , 1999, Journal of Virology.
[7] M. Wainberg,et al. The Role of Pr55gag in the Annealing of tRNA3Lys to Human Immunodeficiency Virus Type 1 Genomic RNA , 1999, Journal of Virology.
[8] R. Gaynor,et al. Functional Domains of Tat Required for Efficient Human Immunodeficiency Virus Type 1 Reverse Transcription , 1999, Journal of Virology.
[9] R. Stauber,et al. Intracellular trafficking and interactions of the HIV-1 Tat protein. , 1998, Virology.
[10] M. Wainberg,et al. Dominance of the E89G Substitution in HIV-1 Reverse Transcriptase in Regard to Increased Polymerase Processivity and Patterns of Pausing* , 1998, The Journal of Biological Chemistry.
[11] G. Morris,et al. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. , 1997, Virology.
[12] R. Bambara,et al. Inhibition of HIV-1 Replication Using a Mutated tRNALys-3 Primer* , 1997, The Journal of Biological Chemistry.
[13] C. Gabus,et al. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. , 1997, Journal of molecular biology.
[14] R. Gaynor,et al. Tat is required for efficient HIV‐1 reverse transcription , 1997, The EMBO journal.
[15] C. Van Lint,et al. Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway , 1997, Science.
[16] C. Ehresmann,et al. Binding and kinetic properties of HIV‐1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. , 1996, The EMBO journal.
[17] B. Berkhout,et al. Role of the DIS hairpin in replication of human immunodeficiency virus type 1 , 1996, Journal of virology.
[18] K. Jeang,et al. Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture , 1996, Journal of virology.
[19] M. Wainberg,et al. Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site , 1996, Journal of virology.
[20] M. Tius,et al. Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[21] C. Ehresmann,et al. Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post‐transcriptional modifications of primer tRNA3Lys. , 1996, The EMBO journal.
[22] B. Roques,et al. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. , 1995, Journal of molecular biology.
[23] T. Masuda,et al. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain , 1995, Journal of virology.
[24] D. Trono,et al. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis , 1995, Journal of virology.
[25] O. Danos,et al. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell , 1995, Journal of virology.
[26] T. Andoh,et al. Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Sodroski,et al. Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.
[28] J. Luban,et al. Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.
[29] K. Jeang,et al. Human immunodeficiency viruses regulated by alternative trans‐activators: genetic evidence for a novel non‐transcriptional function of Tat in virion infectivity. , 1994, The EMBO journal.
[30] M. Wainberg,et al. Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction. , 1994, The Journal of biological chemistry.
[31] T. Spicer,et al. Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. , 1993, AIDS research and human retroviruses.
[32] B. Berkhout,et al. Effects of integration and replication on transcription of the HIV-1 long terminal repeat. , 1993, The Journal of biological chemistry.
[33] D. Trono,et al. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells , 1993, Journal of virology.
[34] Y. Kim,et al. The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression , 1993, Journal of virology.
[35] J. Mak,et al. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1 , 1993, Journal of virology.
[36] D. Dimitrov,et al. Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.
[37] M Chowdhury,et al. TAR‐independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV‐1 gene regulation. , 1992, The EMBO journal.
[38] D. Trono,et al. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses , 1992, Journal of virology.
[39] F. Lori,et al. Viral DNA carried by human immunodeficiency virus type 1 virions , 1992, Journal of virology.
[40] M. Emerman,et al. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene , 1992, Journal of virology.
[41] T. Chang,et al. Identification and characterization of human immunodeficiency virus type 1 gag-pol fusion protein in transfected mammalian cells , 1991, Journal of virology.
[42] S. Segal,et al. Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. , 1990, The EMBO journal.
[43] M. Singh,et al. HIV‐1 tat protein stimulates transcription by binding to a U‐rich bulge in the stem of the TAR RNA structure. , 1990, The EMBO journal.
[44] S. Salahuddin,et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.
[45] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[46] A. Fauci,et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. , 1989, Journal of immunology.
[47] D. Bredt,et al. Tat protein from human immunodeficiency virus forms a metal-linked dimer. , 1988, Science.
[48] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[49] Mark L. Pearson,et al. Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.
[50] A. Rein,et al. Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure , 1984, Journal of virology.
[51] R. Gallo,et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.
[52] R. Bambara,et al. Inhibition of HIV-1 Replication Using a Mutated tRNA Primer* , 1997 .
[53] S. Goff,et al. Reverse Transcriptase and the Generation of Retroviral DNA , 1997 .
[54] B. Peterlin,et al. Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.
[55] S. L. Le Grice,et al. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. , 1990, European journal of biochemistry.
[56] F. Lori,et al. Enzymatically active forms of reverse transcriptase of the human immunodeficiency virus. , 1988, AIDS research and human retroviruses.
[57] T. A. Hagan,et al. Detection , Isolation , and Continuous Production of Cytopathic Retroviruses ( HTLV-III ) from Patients with AIDS and Pre-AIDS , 2022 .